FUM — Futura Medical Share News
0.000.00%
- £2.92m
- -£0.48m
- £1.70m
Brief: Futura Medical Receives European Patent Patent For MED3000 Until 2040
Brief: Futura Medical Says HY Initial Revenues Generated By Eroxon® Of 1.7 Mln Stg
Futura Medical - Interim Results 2023
Futura Medical - Notice of Interim Results
Brief: Futura Medical Says Med3000 Commercialisation Approval In Saudi Arabia
Brief: Futura Medical Appoints Jeff Needham As Non-Exec Chairman
Board Change
UK's Futura Medical surges on license deal for Haleon's ED treatment
Brief: Futura Medical Announces Agreement With Haleon To Commercialise MED3000 In U.S.
Futura/Haleon Enter US Commercialisation Agreement
Recording of Investor Seminar
Futura Medical AGM Statement
Correction - TR-1: Notification of major holdings
TR-1: Notification of major holdings
UK's Futura Medical jumps on FDA nod for OTC sale of topical gel
Brief: Futura Medical's Med3000 Granted Us FDA Approval For OTC Sale
Notice of AGM and availability of Annual Report
TR-1: Notification of major holdings
Directors' / PDMR Dealing and Grant of Options